Advertisement
Advertisement
U.S. markets open in 8 hours 37 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Natera, Inc. (NTRA)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
35.44-1.43 (-3.88%)
At close: 04:00PM EDT
35.71 +0.27 (+0.76%)
After hours: 04:52PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Fast Stochastic

Fast Stochastic

Previous Close36.87
Open36.31
Bid0.00 x 1800
Ask0.00 x 800
Day's Range34.84 - 37.14
52 Week Range26.10 - 129.09
Volume1,018,154
Avg. Volume1,510,967
Market Cap3.413B
Beta (5Y Monthly)1.23
PE Ratio (TTM)N/A
EPS (TTM)-5.89
Earnings DateAug 03, 2022 - Aug 08, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est85.20
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for NTRA

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Natera, Inc.
    Analyst Report: Illumina IncIllumina Inc., based in San Diego, provides sequencing and array-based solutions for genetic analysis. The company's products and services are sold to genomic research centers, academic institutions, government and commercial laboratories, and hospitals, as well as to pharmaceutical, biotech, agrigenomics, and consumer genomics businesses. The company's portfolio of products and services are designed to accelerate and simplify genetic analysis. The company also invests in startup companies that are pursuing promising genomic-related opportunities. It has roughly 9,100 full-time employees. ILMN shares are included in the S&P 500 index.
    Rating
    Fair Value
    Economic Moat
    15 hours agoArgus Research
View more
Advertisement
Advertisement